Endoscopic Mucosal Resection in the Management of Gastric Carcinoid Tumors

Background and Study Aims: Gastric carcinoid tumors are a rare disease. Previously, total gastrectomy was regarded as the treatment of choice. However, differences in biological malignancy have recently led to the increased use of endoscopic mucosal resection (EMR) for treatment. We studied the outcome of EMR in patients with gastric carcinoids who were treated at our hospital and discuss the indications for endoscopic treatment.
Patients and Methods: Between 1986 and 1999 we carried out gastric mucosal resection in five patients with gastric carcinoid tumors. The procedure used for EMR was either strip biopsy or endoscopic aspiration mucosectomy.
Results: The carcinoid tumors measured 10 mm or less in four of the five patients. Two patients had type A gastritis, and all had hypergastrinemia. There was no evidence of recurrence during follow-up (range 6 - 66 months; mean 32.6 months).
Conclusion: EMR is useful in the management of type 1 gastric carcinoids as classified by Rindi (hypergastrinemia; tumor diameter of 10 mm or less).

References

• 1 Gilligan C J, Lawton G P, Tang L H. et al . Gastric carcinoid tumors. The biology and therapy of an enigmatic and controversial lesion.  Am J Gastroenterol. 1995;  90 338-352
• 2 Modlin I M, Gilligan C J, Lawton G P. et al . Gastric carcinoids.  Arch Surg. 1995;  130 250-256
• 3 Tada M, Karita M, Yanai H et al. Evaluation of endoscopic strip biopsy therapeutically used for early gastric cancer.  Stomach Intest. 1998;  23 373-385
• 4 Torii A, Sakai M, Kajiyama T, Kishimoto H. et al . Endoscopic aspiration mucosectomy as curative endoscopic surgery: analysis of 24 cases of early gastric cancer.  Gastrointest Endosc. 1995;  42 475-479
• 5 Japanese Gastric Cancer Association .Japanese Classification of Gastric Carcinoma (in Japanese). 13th edn. Tokyo; Kanehara 1999
• 6 Tanabe S, Koizumi W, Kokutou M. et al . Usefulness of endoscopic aspiration mucosectomy as compared with strip biopsy for the treatment of gastric mucosal cancer.  Gastrointest Endosc. 1999;  6 819-822
• 7 Rindi G, Bordi C, Rappel S. et al . Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior.  World J Surg. 1996;  20 168-172
• 8 Rindi G, Luinetti O, Cornaggia M. et al . Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study.  Gastroenterology. 1993;  104 994-1006
• 9 Stolte M, Ebert D, Seifert E. et al . The prognosis of carcinoid tumors of the stomach.  Leber Magen Darm. 1988;  18 246-256
• 10 Schindl M, Kaserer K, Niederle B. Treatment of gastric neuroendocrine tumors.  Arch Surg. 2001;  136 49-54
• 11 Ahlman H, Kolby L, Lundell L, Olbe L. et al . Clinical management of gastric carcinoid tumors.  Digestion. 1994;  55 77-85